HealthSouth Corp (NYSE:HLS) Director’s John Maupin and John Chidsey were awarded with stock grants yesterday. While Maupin received 180 shares with a value of $36.10 each, Chidsey was awarded 775 shares at the same value. However, except for the grants awarded, insider trading has been very still over the past months at the $3.1 billion market cap healthcare facility enterprise. In fact, the last stock sale was executed by the firm’s President and Chief Executive Officer, Jay Grinney, in May, when the insider unloaded 20,000 shares, paying a price of $33.59 per share.
On another note, Q1 of this fiscal year showed some stability amongst hedge funds, with little changes regarding HealthSouth Corp’s portfolio participation. Mariko Gordon’s hedge fund, Daruma Asset Management, decreased the firm’s portfolio participation by 20%, and now accounts for 2.67% of overall holdings, with 1.87 million shares, worth $67.3 million. Nevertheless, the largest shareholder position is still held by John Osterweis’ Osterweis Capital Management, with 2.59 million company shares, worth $93.1 million.